Impact of genetic background on nephropathy in diabetic mice - PubMed (original) (raw)
Comparative Study
. 2006 Jan;290(1):F214-22.
doi: 10.1152/ajprenal.00204.2005. Epub 2005 Aug 23.
Affiliations
- PMID: 16118394
- DOI: 10.1152/ajprenal.00204.2005
Free article
Comparative Study
Impact of genetic background on nephropathy in diabetic mice
Susan B Gurley et al. Am J Physiol Renal Physiol. 2006 Jan.
Free article
Abstract
With the goal of identifying optimal platforms for developing better models of diabetic nephropathy in mice, we compared renal effects of streptozotocin (STZ)-induced diabetes among five common inbred mouse strains (C57BL/6, MRL/Mp, BALB/c, DBA/2, and 129/SvEv). We also evaluated the renal consequences of chemical and genetic diabetes on the same genetic background (C57BL/6). There was a hierarchical response of blood glucose level to the STZ regimen among the strains (DBA/2 > C57BL/6 > MRL/MP > 129/SvEv > BALB/c). In all five strains, males demonstrated much more robust hyperglycemia with STZ than females. STZ-induced diabetes was associated with modest levels of albuminuria in all of the strains but was greatest in the DBA/2 strain, which also had the most marked hyperglycemia. Renal structural changes on light microscopy were limited to the development of mesangial expansion, and, while there were some apparent differences among strains in susceptibility to renal pathological changes, there was a significant positive correlation between blood glucose and the degree of mesangial expansion, suggesting that most of the variability in renal pathological abnormalities was because of differences in hyperglycemia. Although the general character of renal involvement was similar between chemical and genetic diabetes, Akita mice developed more marked hyperglycemia, elevated blood pressures, and less variability in renal structural responses. Thus, among the strains and models tested, the DBA/2 genetic background and the Akita (Ins2(+/C96Y)) model may be the most useful platforms for model development.
Similar articles
- Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.
Gurley SB, Mach CL, Stegbauer J, Yang J, Snow KP, Hu A, Meyer TW, Coffman TM. Gurley SB, et al. Am J Physiol Renal Physiol. 2010 Mar;298(3):F788-95. doi: 10.1152/ajprenal.90515.2008. Epub 2009 Dec 30. Am J Physiol Renal Physiol. 2010. PMID: 20042456 Free PMC article. - A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
Inada A, Kanamori H, Arai H, Akashi T, Araki M, Weir GC, Fukatsu A. Inada A, et al. J Cell Physiol. 2008 May;215(2):383-91. doi: 10.1002/jcp.21316. J Cell Physiol. 2008. PMID: 18270980 - A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE, Rinchik EM, Polosukhina D, Davis LS, Kadkina V, Mohamed Y, Dunn SR, Sharma K, Qi Z, Fogo AB, Breyer MD. Tchekneva EE, et al. J Am Soc Nephrol. 2007 Jan;18(1):103-12. doi: 10.1681/ASN.2006020164. Epub 2006 Dec 6. J Am Soc Nephrol. 2007. PMID: 17151334 - Rodent models of streptozotocin-induced diabetic nephropathy.
Tesch GH, Allen TJ. Tesch GH, et al. Nephrology (Carlton). 2007 Jun;12(3):261-6. doi: 10.1111/j.1440-1797.2007.00796.x. Nephrology (Carlton). 2007. PMID: 17498121 Review. - Diabetic kidney disease in the db/db mouse.
Sharma K, McCue P, Dunn SR. Sharma K, et al. Am J Physiol Renal Physiol. 2003 Jun;284(6):F1138-44. doi: 10.1152/ajprenal.00315.2002. Am J Physiol Renal Physiol. 2003. PMID: 12736165 Review.
Cited by
- SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
Fujita H, Fujishima H, Takahashi K, Sato T, Shimizu T, Morii T, Shimizu T, Shirasawa T, Qi Z, Breyer MD, Harris RC, Yamada Y, Takahashi T. Fujita H, et al. Metabolism. 2012 Dec;61(12):1714-24. doi: 10.1016/j.metabol.2012.05.005. Epub 2012 May 25. Metabolism. 2012. PMID: 22632894 Free PMC article. - Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
Binz N, Rakoczy EP, Ali Rahman IS, Vagaja NN, Lai CM. Binz N, et al. PLoS One. 2016 Aug 2;11(8):e0160442. doi: 10.1371/journal.pone.0160442. eCollection 2016. PLoS One. 2016. PMID: 27482904 Free PMC article. - The missing link: studying the alternative TGF-β pathway provides a unifying theory for different components of diabetic nephropathy.
Zheng X, Bhalla V. Zheng X, et al. Diabetes. 2015 Jun;64(6):1898-900. doi: 10.2337/db15-0184. Diabetes. 2015. PMID: 25999532 Free PMC article. No abstract available. - Mouse models of diabetic nephropathy.
Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T; Animal Models of Diabetic Complications Consortium. Brosius FC 3rd, et al. J Am Soc Nephrol. 2009 Dec;20(12):2503-12. doi: 10.1681/ASN.2009070721. Epub 2009 Sep 3. J Am Soc Nephrol. 2009. PMID: 19729434 Free PMC article. Review. - The impact of genetic background on mouse models of kidney disease.
Bufi R, Korstanje R. Bufi R, et al. Kidney Int. 2022 Jul;102(1):38-44. doi: 10.1016/j.kint.2022.03.020. Epub 2022 Apr 13. Kidney Int. 2022. PMID: 35429495 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases